Nutraceuticals and their potential to treat duchenne muscular dystrophy: Separating the credible from the conjecture
Loading...
Download
Associated Records
Authors
File Licence
Editors
Date
2016-11-01
Source Title
Nutrients
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Melbourne Authors
Affiliation
Melbourne Veterinary School
Paediatrics (RCH)
Agriculture and Food Systems
Veterinary Biosciences
Paediatrics (RCH)
Agriculture and Food Systems
Veterinary Biosciences
Document Type
Journal Article
Subject Code
Citation
Woodman, K. G., Coles, C. A., Lamandé, S. R. & White, J. D. (2016). Nutraceuticals and their potential to treat duchenne muscular dystrophy: Separating the credible from the conjecture. Nutrients, 8 (11), https://doi.org/10.3390/nu8110713.
Access Status
Open Access
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
In recent years, complementary and alternative medicine has become increasingly popular. This trend has not escaped the Duchenne Muscular Dystrophy community with one study showing that 80% of caregivers have provided their Duchenne patients with complementary and alternative medicine in conjunction with their traditional treatments. These statistics are concerning given that many supplements are taken based on purely "anecdotal" evidence. Many nutraceuticals are thought to have anti-inflammatory or anti-oxidant effects. Given that dystrophic pathology is exacerbated by inflammation and oxidative stress these nutraceuticals could have some therapeutic benefit for Duchenne Muscular Dystrophy (DMD). This review gathers and evaluates the peer-reviewed scientific studies that have used nutraceuticals in clinical or pre-clinical trials for DMD and thus separates the credible from the conjecture.